Magnifying Glass
Search Loader

Author: Anne B. Claiborne

Support

26 Ebooks by Anne B. Claiborne

Board on Health Sciences Policy & Institute of Medicine: Building a National Framework for the Establishment of Regulatory Science for Drug Development
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA’s science base must be strong enough to make certain that regulatory decisions are based …
PDF
English
DRM
€24.88
Board on Health Sciences Policy & Institute of Medicine: Building a National Framework for the Establishment of Regulatory Science for Drug Development
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA’s science base must be strong enough to make certain that regulatory decisions are based …
EPUB
English
DRM
€36.18
Board on Health Sciences Policy & Forum on Medical and Public Health Preparedness for Catastrophic Events: Advancing Regulatory Science for Medical Countermeasure Development
Whether or not the United States has safe and effective medical countermeasures–such as vaccines, drugs, and diagnostic tools–available for use during a disaster can mean the difference between …
PDF
English
DRM
€53.52
Board on Health Sciences Policy & Forum on Medical and Public Health Preparedness for Catastrophic Events: Advancing Regulatory Science for Medical Countermeasure Development
Whether or not the United States has safe and effective medical countermeasures–such as vaccines, drugs, and diagnostic tools–available for use during a disaster can mean the difference between …
EPUB
English
DRM
€55.88
Board on Health Sciences Policy & Institute of Medicine: Public Engagement and Clinical Trials
Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether …
PDF
English
DRM
€3.75
Board on Health Sciences Policy & Institute of Medicine: Public Engagement and Clinical Trials
Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether …
EPUB
English
DRM
€50.34
Board on Health Sciences Policy & Institute of Medicine: Facing the Reality of Drug-Resistant Tuberculosis in India
An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a …
PDF
English
DRM
€3.76
Board on Health Sciences Policy & Institute of Medicine: Facing the Reality of Drug-Resistant Tuberculosis in India
An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a …
EPUB
English
DRM
€63.39
Board on Health Sciences Policy & Institute of Medicine: Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
The development and application of regulatory science – which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and …
PDF
English
DRM
€3.77
Board on Health Sciences Policy & Institute of Medicine: Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
The development and application of regulatory science – which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and …
EPUB
English
DRM
€38.06
Board on Health Sciences Policy & Institute of Medicine: Envisioning a Transformed Clinical Trials Enterprise in the United States
There is growing recognition that the United States’ clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired – where medical care is provided solely based on …
PDF
English
DRM
€3.76
Board on Health Sciences Policy & Institute of Medicine: Envisioning a Transformed Clinical Trials Enterprise in the United States
There is growing recognition that the United States’ clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired – where medical care is provided solely based on …
EPUB
English
DRM
€60.37
Board on Health Sciences Policy & Institute of Medicine: Accelerating the Development of New Drugs and Diagnostics
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite …
PDF
English
DRM
€3.80
Board on Health Sciences Policy & Institute of Medicine: Accelerating the Development of New Drugs and Diagnostics
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite …
EPUB
English
DRM
€48.25
Board on Health Sciences Policy & Institute of Medicine: Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of …
PDF
English
DRM
€3.73
Board on Health Sciences Policy & Institute of Medicine: Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of …
EPUB
English
DRM
€54.33
Board on Health Sciences Policy & Institute of Medicine: Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and …
PDF
English
DRM
€3.76
Board on Health Sciences Policy & Institute of Medicine: Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and …
EPUB
English
DRM
€58.34
Board on Health Sciences Policy & Institute of Medicine: Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors …
PDF
English
DRM
€3.76
Board on Health Sciences Policy & Institute of Medicine: Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors …
EPUB
English
DRM
€57.30
Board on Health Sciences Policy & Institute of Medicine: Global Health Risk Framework
Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond …
PDF
English
DRM
€3.76
Board on Health Sciences Policy & Institute of Medicine: Global Health Risk Framework
Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond …
EPUB
English
DRM
€53.99
Board on Health Sciences Policy & Health and Medicine Division: Advancing the Discipline of Regulatory Science for Medical Product Development
The field of endeavors known as regulatory science has grown out of the need to link and integrate knowledge within and among basic science research, clinical research, clinical medicine, and other …
PDF
English
DRM
€3.77
Board on Health Sciences Policy & Health and Medicine Division: Advancing the Discipline of Regulatory Science for Medical Product Development
The field of endeavors known as regulatory science has grown out of the need to link and integrate knowledge within and among basic science research, clinical research, clinical medicine, and other …
EPUB
English
DRM
€48.82
Board on Health Sciences Policy & Health and Medicine Division: Real-World Evidence Generation and Evaluation of Therapeutics
The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the …
PDF
English
DRM
€3.79
Board on Health Sciences Policy & Health and Medicine Division: Real-World Evidence Generation and Evaluation of Therapeutics
The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the …
EPUB
English
DRM
€68.66